+
Home
+
How to Order
+
LentiDesign
+
Investors
+
Contact
Username
Password
Forgot your password?
New user?
Sign up for a free account.
Lentigen Licenses Fundamental Lentiviral Vector Technology Patent from the University of Cambridge [pdf]
Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer [pdf]
Lentigen to Move Headquarters and Manufacturing to Gaithersburg [pdf]
May 28 – Jun 01, 2008
American Society of Gene Therapy, Booth # 205
|
Boston, MA
June 17 – 20, 2008
BIO CONFERENCE, Booth # 5242
|
San Diego, CA
August 04 – 07, 2008
DRUG DISCOVERY TECHNOLOGY, Booth # 817
|
Boston, MA
What Are Lentiviral Vectors
LentiMax™
LentiMax Safety
Gene Delivery Data
Frequently Asked Questions
Custom Vectors
Stock Products
Cell Line Development
Order a Vector
Send Your Construct for Manufacture
Large-Scale Manufacture
cGMP Manufacture
Release Testing Assays
Influenza Vaccine
Current Partnerships
Become a Partner
Corporate Overview
News
Management
Board of Directors
Investor Relations
Careers
Location
© Copyright 2005, 2006 Lentigen Corp. All Rights Reserved.
+
Privacy Policy
+
Terms of Use